Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Sports
Business
Health & Fitness
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d1/6f/9f/d16f9f26-1982-d745-6aa0-288574c187ca/mza_6348993118871209209.jpg/600x600bb.jpg
Life Sciences 360
Harsh Thakkar
86 episodes
1 month ago
Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator). Learn how AI in biotech is tackling the complexities of medical affairs—from literature review and content automation to compliance and regulatory writing. ⚡️ WHAT YOU’LL LEARN: - Why medical affairs and regulatory teams can’t rely on ChatGPT alone. - How MACg integrates real‑t...
Show more...
Life Sciences
Science
RSS
All content for Life Sciences 360 is the property of Harsh Thakkar and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator). Learn how AI in biotech is tackling the complexities of medical affairs—from literature review and content automation to compliance and regulatory writing. ⚡️ WHAT YOU’LL LEARN: - Why medical affairs and regulatory teams can’t rely on ChatGPT alone. - How MACg integrates real‑t...
Show more...
Life Sciences
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d1/6f/9f/d16f9f26-1982-d745-6aa0-288574c187ca/mza_6348993118871209209.jpg/600x600bb.jpg
VC Money Tight? Here’s How Startups Still Land Top Talent (2025)
Life Sciences 360
46 minutes
2 months ago
VC Money Tight? Here’s How Startups Still Land Top Talent (2025)
What happens when 3,500 staffers lose their jobs due to FDA layoffs, venture capital (VC) term sheets shrink, and AI drug-discovery startups raise $600 million rounds? Executive recruiter William Holodnak (ex-Fidelity, global biotech headhunter) breaks down 2025’s wild hiring market—and how founders can still build A-teams. In this episode you’ll learn: - Why the April-1 FDA layoffs could delay approvals—and open new career doors for ex-regulators. - The three traits VCs deman...
Life Sciences 360
Medical misinformation, life sciences burnout, and AI-powered content creation collide in this episode with Dr. Ome Ogbru, founder & CEO of AINGENS and creator of MACg (Medical Affairs Content Generator). Learn how AI in biotech is tackling the complexities of medical affairs—from literature review and content automation to compliance and regulatory writing. ⚡️ WHAT YOU’LL LEARN: - Why medical affairs and regulatory teams can’t rely on ChatGPT alone. - How MACg integrates real‑t...